Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab for cryptogenic cirrhosis
IRCT2016052228003N1Phase 2Completed
- Sponsor
- Research Center for Infectious Diseases of Digestive System
- Start
- Jul 2016
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, single-arm trial of infliximab in Cirrhosis, sponsored by Research Center for Infectious Diseases of Digestive System. Started Jul 2016; status: completed.
02
Drugs
infliximab
03
Conditions
Cirrhosis
Beyond the preview
Go deeper on IRCT2016052228003N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016052228003N1.